---
figid: PMC8013598__10.1177_1758835920982853-fig1
figlink: pmc/articles/PMC8013598/figure/fig1-1758835920982853/
number: F1
caption: Schematic of the ATR-Chk1 pathway. The oncogene promotes replication stress
  and DNA damage alongside radiotherapy and chemotherapy. In response, ATR kinase
  is preferentially activated. ATR then phosphorylates and hence activates Chk1. Chk1
  then promotes DNA damage repair during G2/M cell cycle arrest. In brief, activated
  p-Chk1 phosphorylates and thus inactivates Cdc25c, which in turn inhibits the Cdc2-cyclin
  A/B complex through decreased dephosphorylation at Tyr15. This ultimately causes
  cell cycle arrest at G2. When ATR is knocked down or inhibited, p-Chk1 levels and
  downstream pCdc25c levels decrease. This increases the activity of the Cdc25c dephosphorylates
  pCdc2 (Tyr15), an inactive Cdc2 form, ultimately promoting mitosis.ATR, ataxia-telangiectasia
  and Rad3 related; Chk1, checkpoint kinase 1.
pmcid: PMC8013598
papertitle: ATR and p-ATR are emerging prognostic biomarkers and DNA damage response
  targets in ovarian cancer.
reftext: Wenlong Feng, et al. Ther Adv Med Oncol. 2020;12:1758835920982853.
pmc_ranked_result_index: '4546'
pathway_score: 0.9326962
filename: 10.1177_1758835920982853-fig1.jpg
figtitle: The ATR-Chk1 pathway
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8013598__10.1177_1758835920982853-fig1.html
  '@type': Dataset
  description: Schematic of the ATR-Chk1 pathway. The oncogene promotes replication
    stress and DNA damage alongside radiotherapy and chemotherapy. In response, ATR
    kinase is preferentially activated. ATR then phosphorylates and hence activates
    Chk1. Chk1 then promotes DNA damage repair during G2/M cell cycle arrest. In brief,
    activated p-Chk1 phosphorylates and thus inactivates Cdc25c, which in turn inhibits
    the Cdc2-cyclin A/B complex through decreased dephosphorylation at Tyr15. This
    ultimately causes cell cycle arrest at G2. When ATR is knocked down or inhibited,
    p-Chk1 levels and downstream pCdc25c levels decrease. This increases the activity
    of the Cdc25c dephosphorylates pCdc2 (Tyr15), an inactive Cdc2 form, ultimately
    promoting mitosis.ATR, ataxia-telangiectasia and Rad3 related; Chk1, checkpoint
    kinase 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATR
  - CHEK1
  - CDC25C
  - POLD1
  - CCNB1
  - CCNC
  - CCND2
  - CCNE1
  - CCNG1
  - CCNG2
  - CCNH
  - CCNT1
  - CCNK
  - CCNA1
  - CCNB2
  - CCNO
  - CCNI
  - CCNJL
  - CCNY
  - CCND1
  - CCNA2
  - CCND3
  - CCNF
  - CCNT2
  - CCNE2
  - CCNJ
  - CCNL1
  - CCNL2
  - CCNB3
  - CCNYL1
  - CCNI2
  - Cancer
genes:
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: Chk1
  symbol: CHK1
  source: hgnc_alias_symbol
  hgnc_symbol: CHEK1
  entrez: '1111'
- word: Cdc25c
  symbol: CDC25C
  source: hgnc_symbol
  hgnc_symbol: CDC25C
  entrez: '995'
- word: Cdc2
  symbol: CDC2
  source: hgnc_alias_symbol
  hgnc_symbol: POLD1
  entrez: '5424'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNB1
  entrez: '891'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNC
  entrez: '892'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNG1
  entrez: '900'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNG2
  entrez: '901'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNH
  entrez: '902'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNT1
  entrez: '904'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNK
  entrez: '8812'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNA1
  entrez: '8900'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNB2
  entrez: '9133'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNO
  entrez: '10309'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNI
  entrez: '10983'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNJL
  entrez: '79616'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNY
  entrez: '219771'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNA2
  entrez: '890'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNF
  entrez: '899'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNT2
  entrez: '905'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNJ
  entrez: '54619'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNL1
  entrez: '57018'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNL2
  entrez: '81669'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNB3
  entrez: '85417'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNYL1
  entrez: '151195'
- word: Сyclin
  symbol: Cyclin
  source: bioentities_symbol
  hgnc_symbol: CCNI2
  entrez: '645121'
chemicals: []
diseases:
- word: Cancer
  source: MESH
  identifier: D009369
figid_alias: PMC8013598__F1
redirect_from: /figures/PMC8013598__F1
figtype: Figure
---
